TBRG
TruBridge, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$26.24
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 345.9M | 346.8M | 342.6M | 339.4M | 326.6M |
| Cost of Revenue | 168.7M | 163.0M | 168.5M | 175.9M | 166.5M |
| Gross Profit | 177.2M | 183.9M | 174.1M | 163.6M | 160.1M |
| Operating Expenses | |||||
| R&D Expense | 39.9M | 32.6M | 34.5M | 37.2M | 30.9M |
| SG&A Expense | 109.9M | 104.2M | 104.1M | 104.2M | 82.1M |
| General & Admin Expense | 85.4M | 80.7M | 77.0M | 76.2M | 55.0M |
| Selling & Marketing Expense | 24.5M | 23.5M | 27.1M | 28.0M | 27.1M |
| Other Expenses | 6.9M | 26.3M | 29.0M | 64.7M | 24.3M |
| Total Operating Expenses | 156.6M | 163.0M | 167.5M | 206.2M | 137.3M |
| Cost and Expenses | 325.3M | 326.0M | 336.0M | 382.0M | 303.9M |
| Operating Income (EBIT) | 20.6M | 20.8M | 6.6M | (42.6M) | 22.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 6.3M | 12.3M | 16.2M | 12.5M | 6.3M |
| Net Interest Income | (6.3M) | (12.3M) | (16.2M) | (12.5M) | (6.3M) |
| Other Non-Op Income/Expense | (21.1M) | (17.0M) | (16.8M) | (11.8M) | (4.7M) |
| Non-Operating Income (excl Interest) | 14.8M | 4.6M | 670.0K | (745.0K) | (1.6M) |
| EBT (Pre-Tax Income) | (471.0K) | 3.9M | (10.2M) | (54.4M) | 18.1M |
| Income Tax Expense | (4.9M) | (485.0K) | 10.2M | (8.6M) | 2.2M |
| Bottom Line | |||||
| Net Income | 4.4M | 4.4M | (20.4M) | (45.8M) | 15.9M |
| Earnings from Cont. Ops | 4.4M | 4.4M | (20.4M) | (45.8M) | 15.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 4.3M | 4.2M | (19.7M) | (44.8M) | 15.6M |
| Per Share | |||||
| Basic EPS | $0.29 | $0.29 | ($1.38) | ($3.15) | $1.08 |
| Diluted EPS | $0.29 | $0.29 | ($1.38) | ($3.15) | $1.08 |
| Revenue Per Share | $23.75 | $23.94 | $23.96 | $23.93 | $22.75 |
| Shares | |||||
| Basic Shares Outstanding | 14.6M | 14.5M | 14.3M | 14.2M | 14.4M |
| Diluted Shares Outstanding | 14.6M | 14.5M | 14.3M | 14.2M | 14.4M |
| Profitability Metrics | |||||
| EBITDA | 32.6M | 42.5M | 34.9M | (15.4M) | 47.7M |
| D&A | 26.7M | 26.3M | 29.0M | 26.5M | 23.3M |
| EBIT | 5.8M | 16.2M | 6.0M | (41.9M) | 24.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026